Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level.
antimicrobial resistance
modelling
predictions
surveillance
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
entrez:
20
6
2020
pubmed:
20
6
2020
medline:
29
12
2020
Statut:
ppublish
Résumé
BackgroundThe spread of antimicrobial resistance (AMR) is of worldwide concern. Public health policymakers and pharmaceutical companies pursuing antibiotic development require accurate predictions about the future spread of AMR.AimWe aimed to identify and model temporal and geographical patterns of AMR spread and to predict future trends based on a slow, intermediate or rapid rise in resistance.MethodsWe obtained data from five antibiotic resistance surveillance projects spanning the years 1997 to 2015. We aggregated the isolate-level or country-level data by country and year to produce country-bacterium-antibiotic class triads. We fitted both linear and sigmoid models to these triads and chose the one with the better fit. For triads that conformed to a sigmoid model, we classified AMR progression into one of three characterising paces: slow, intermediate or fast, based on the sigmoid slope. Within each pace category, average sigmoid models were calculated and validated.ResultsWe constructed a database with 51,670 country-year-bacterium-antibiotic observations, grouped into 7,440 country-bacterium-antibiotic triads. A total of 1,037 triads (14%) met the inclusion criteria. Of these, 326 (31.4%) followed a sigmoid (logistic) pattern over time. Among 107 triads for which both sigmoid and linear models could be fit, the sigmoid model was a better fit in 84%. The sigmoid model deviated from observed data by a median of 6.5%; the degree of deviation was related to the pace of spread.ConclusionWe present a novel method of describing and predicting the spread of antibiotic-resistant organisms.
Identifiants
pubmed: 32553060
doi: 10.2807/1560-7917.ES.2020.25.23.1900387
pmc: PMC7403637
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9
pubmed: 16355321
Curr Opin Infect Dis. 2011 Jun;24(3):279-87
pubmed: 21467930
J Infect Dis. 2017 Feb 15;215(suppl_1):S71-S77
pubmed: 28375517
Clin Infect Dis. 2014 Mar;58(5):697-703
pubmed: 24304707
Antimicrob Agents Chemother. 2006 Apr;50(4):1257-62
pubmed: 16569837
J Antimicrob Chemother. 2011 Apr;66 Suppl 2:ii41-7
pubmed: 20852273
Nat Rev Microbiol. 2008 Nov;6(11):827-37
pubmed: 18923410
N Engl J Med. 1997 Aug 14;337(7):441-6
pubmed: 9250845
Clin Infect Dis. 2018 Feb 1;66(4):612-616
pubmed: 29020246
Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1152-6
pubmed: 9927709
Antimicrob Resist Infect Control. 2018 Apr 25;7:58
pubmed: 29713465
Lancet Glob Health. 2018 Sep;6(9):e969-e979
pubmed: 30103998
Arch Intern Med. 2002 Jan 28;162(2):185-90
pubmed: 11802752
Science. 2015 Mar 13;347(6227):aaa4339
pubmed: 25766240
Bull World Health Organ. 1962;26:241-52
pubmed: 14477181
Int J Infect Dis. 2018 Mar;68:50-53
pubmed: 29410253
Infect Control Hosp Epidemiol. 2005 Feb;26(2):166-74
pubmed: 15756888
Clin Infect Dis. 2003 Jun 1;36(11):1433-7
pubmed: 12766839
Lancet Infect Dis. 2018 Mar;18(3):e99-e106
pubmed: 29102325
Antimicrob Resist Infect Control. 2018 Sep 29;7:117
pubmed: 30288257